# Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease

> **NCT03478332** · PHASE2 · UNKNOWN · sponsor: **Affiliated Hospital of Changchun University of Chinese Medicine** · enrollment: 90 (estimated)

## Conditions studied

- Coronary Heart Disease

## Interventions

- **DRUG:** Yangxinshi pill
- **DRUG:** conventional coronary heart disease medicine
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03478332
- **Lead sponsor:** Affiliated Hospital of Changchun University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-01
- **Primary completion:** 2020-05-02
- **Final completion:** 2020-08-25
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03478332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03478332, "Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03478332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*